ArticleTremor and other hyperkinetic movements (New York, N.Y.)2025
A Scoping Review of Measures Used to Assess Stress-Related Motor Dysfunction in Functional Movement Disorder.
Article in Tremor and other hyperkinetic movements (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neurofeedback for functional neurological disorders: future directions for research and clinical practice.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional Neurological Disorder (FND) is a complex condition characterized by a range of motor and non-motor symptoms, including tremors, dystonia, sensory disturbances and dissociative episodes. Functional Movement Disorder (FMD), a common motor subtype of FND, specifically involves abnormal involuntary movements without an identifiable structural or organic cause. There isn't a validated assessment tool that currently exists to measure the specific impact of stress on motor symptom variability in FMD. The absence of such tools presents a barrier to accurate diagnosis, treatment planning, and longitudinal monitoring. This review focuses specifically on the FMD subtype, as it represents the most relevant phenotype for assessing stress-related motor dysfunction in the context of movement disorders. Following PRISMA-ScR guidelines, a systematic search was conducted across four major databases-PubMed, PsycINFO, Embase, and Scopus-using keywords related to FND, stress, motor symptoms, and psychometric evaluation. A total of 15 studies met inclusion criteria. Findings reveal a gap in available instruments: while several measures assess general stress (e.g., PSS-10, DASS-21) or motor symptoms (e.g., S-FMDRS), none are designed to capture the dynamic and stress-sensitive nature of motor dysfunction in FND. The review underscores the need for a patient-reported outcome (PRO) measure that is condition-specific, psychometrically validated, and capable of assessing real-time symptom variability linked to stress. Such a tool may offer significant benefits for clinical care and research by improving the precision of symptom monitoring, enhancing patient-provider communication, and guiding targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.